Stock Track | 4DMedical Soars 5.00% Intraday on FDA Approval and US$1.1 Billion Market Potential

Stock Track

03/02

4DMedical Limited's stock surged 5.00% during Monday's intraday trading session, reflecting heightened investor interest in the medical imaging company.

The significant price movement appears to be driven by recent developments regarding the company's CT:VQ imaging platform. According to recent reports, 4DMedical has received FDA 510(k) clearance and CMS reimbursement approval for its CT:VQ product, positioning it for commercial deployment in the United States.

The company has highlighted an initial addressable U.S. market exceeding US$1.10 billion annually for the newly approved CT:VQ imaging technology. This substantial market opportunity, combined with regulatory clearance, has likely contributed to investor optimism about the company's growth prospects despite recent financial results showing continued investment in product development and commercialization.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1154718745"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1154718745\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1154718745?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-02 08:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1154718745","market":"us","top_or_hot":-1,"title":"Stock Track | 4DMedical Soars 5.00% Intraday on FDA Approval and US$1.1 Billion Market Potential","media":"Stock Track","content":"<p>4DMedical Limited's stock surged 5.00% during Monday's intraday trading session, reflecting heightened investor interest in the medical imaging company.</p><p>The significant price movement appears to be driven by recent developments regarding the company's CT:VQ imaging platform. According to recent reports, 4DMedical has received FDA 510(k) clearance and CMS reimbursement approval for its CT:VQ product, positioning it for commercial deployment in the United States.</p><p>The company has highlighted an initial addressable U.S. market exceeding US$1.10 billion annually for the newly approved CT:VQ imaging technology. This substantial market opportunity, combined with regulatory clearance, has likely contributed to investor optimism about the company's growth prospects despite recent financial results showing continued investment in product development and commercialization.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | 4DMedical Soars 5.00% Intraday on FDA Approval and US$1.1 Billion Market Potential</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | 4DMedical Soars 5.00% Intraday on FDA Approval and US$1.1 Billion Market Potential\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2026-03-02 08:08</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>4DMedical Limited's stock surged 5.00% during Monday's intraday trading session, reflecting heightened investor interest in the medical imaging company.</p><p>The significant price movement appears to be driven by recent developments regarding the company's CT:VQ imaging platform. According to recent reports, 4DMedical has received FDA 510(k) clearance and CMS reimbursement approval for its CT:VQ product, positioning it for commercial deployment in the United States.</p><p>The company has highlighted an initial addressable U.S. market exceeding US$1.10 billion annually for the newly approved CT:VQ imaging technology. This substantial market opportunity, combined with regulatory clearance, has likely contributed to investor optimism about the company's growth prospects despite recent financial results showing continued investment in product development and commercialization.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"4DX.AU","symbol_name":"4DMEDICAL LTD","start_time":0,"source_url":"","article_id":"1154718745","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1154718745","pubTimestamp":1772410109,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"4DMedical Limited's stock surged 5.00% during Monday's intraday trading session, reflecting heightened investor interest in the medical imaging company.The significant price movement appears to be...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"4DX.AU":"4DMEDICAL LTD"},"translate_title":"个股追踪|4DMedical盘中大涨5.00%获FDA批准及11亿美元市场潜力","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"4DX.AU":1},"content_text":"4DMedical Limited's stock surged 5.00% during Monday's intraday trading session, reflecting heightened investor interest in the medical imaging company.The significant price movement appears to be driven by recent developments regarding the company's CT:VQ imaging platform. According to recent reports, 4DMedical has received FDA 510(k) clearance and CMS reimbursement approval for its CT:VQ product, positioning it for commercial deployment in the United States.The company has highlighted an initial addressable U.S. market exceeding US$1.10 billion annually for the newly approved CT:VQ imaging technology. This substantial market opportunity, combined with regulatory clearance, has likely contributed to investor optimism about the company's growth prospects despite recent financial results showing continued investment in product development and commercialization.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}